Drug delivery Systems (DDSs) are polymeric or lipid carrier systems that transport medications to their targets or receptor sites in a way that ensures their maximum Therapeutic Activity, prevents drug degradation or inactivation while travelling to the target site (s), and shields the body from negative effects caused by inadvertent administration. It can be characterised as a formulation or a tool that permits the entrance of a medicinal material into the body and increases its efficacy and safety by regulating the rate, timing, and site of drug release.
Release of the drug(s) with the highest levels of safety, effectiveness, and dependability is the aim of an ideal DDS. Combining a number of cutting-edge methods, the Novel Drug Delivery System (NDDS), also known as controlled DDS In order to improve medication potency, control drug release, increase safety, and specifically target a drug to a targeted region, novel drug delivery systems (NDDS), also known as Controlled DDS, combine cutting-edge technology and innovative dosage forms. The definition of "controlled release" extends beyond actions that solely include continuous release. In other words, the release kinetics of controlled release must be able to be predicted and replicated.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India